The Danish Reference Genome

After close to 5 years of work, the GenomeDenmark consortium has now finalized the efforts to establish a Danish Reference genome. The result is a reference of unrivalled quality and information depth, as compared to other similar international references and studies. Due to the unique and high quality approach, the consortium consisting of three Danish universities and the genomics company BGI Europe has been able to analyze otherwise intractable genomics regions for the first time.

Furthermore and also for the first time, the Danish study has thoroughly mapped non-simple variation among individuals. Such information increases our understanding of how genetic differences affect the health and development of disease for individuals – and is the basis for implementation of the precision medicine concept. The reference genome work is published in the leading scientific journal Nature at a time, where the Danish Regions (responsible for the Danish hospitals) and the Health Ministry is ramping up the national Precision Medicine initiative with a newly established National Genomics Center.

The GenomeDenmark project leader Prof. Karsten Kristiansen, Department of Biology, University of Copenhagen says: "With a combined national effort and unique approach, we have demonstrated that even a relatively small consortium can provide an important new genomics standard to the scientific community. We see our approach as part of the basis for the precision medicine agenda and hope that the national funding bodies and government will exploit the opportunity to increase the Danish efforts in this area - to improve the future public health and capture a health economics impact."

Mikkel Heide Schierup, Department of Bioscience, Aarhus University, one of the leading professors behind the study continues: "Even though we sequence relatively few samples (150 persons), our approach allows us to build each genome separately. This makes us independent from external references and therefore allows us to discover a much larger catalogue of complex variation than before. Actually as much as 92% of the hundreds of thousands larger structural variations we identified were novel and missed in previous studies.

"There is a lot of genetic variation related to the heritability of human diseases that awaits discovery. Therefore, continued research in this field is central for the clinical impact of genomics.

Søren Brunak, another leading GenomeDenmark professor from the Center for Protein Research at the University of Copenhagen and the Department for Bio and Health Informatics at the Technical University of Denmark explains: "We know that further research is needed to establish causative relations between many of the new genotypes discovered and disease. However, due to the world-class Danish health registers and longitudinal studies, we are uniquely positioned to couple genomics and other types of health data large scale in Denmark. And we are heading that way, hoping to be able to keep our ambitions high."

For more information about the GenomeDenmark consortium and the Danish Reference Genome, please visit:
http://www.genomedenmark.dk

Most Popular Now

Clanwilliam Brings Epic Care to the UK

Care homes looking to digitise their administration and care procedures have a new option with the launch of Epic Care in the UK. Epic Care is a modular, scalable system developed...

AI Language Models Write Good Doctor…

Generative AI should be able to write usable doctor's letters and thus potentially speed up medical documentation, according to a study by the University Medical Center Freiburg. Around 93% of...

West Yorkshire and Harrogate Hospitals S…

Clinicians working at five of the six trusts in the West Yorkshire Association of Acute Trusts (WYAAT) can access test results from across their pathology network, following a summer roll-out...

ChatGPT Shows Human-Level Assessment of …

As artificial intelligence advances, its uses and capabilities in real-world applications continue to reach new heights that may even surpass human expertise. In the field of radiology, where a correct...

When Detecting Depression, the Eyes have…

It has been estimated that nearly 300 million people, or about 4% of the global population, are afflicted by some form of depression. But detecting it can be difficult, particularly...

When it comes to Emergency Care, ChatGPT…

If ChatGPT were cut loose in the Emergency Department, it might suggest unneeded x-rays and antibiotics for some patients and admit others who didn't require hospital treatment, a new study...

HWL 2024 Brings Together a Record Number…

1 - 2 October 2024, Luxembourg. The second edition of Healthcare Week Luxembourg on 1 and 2 October 2024, organised by the Federation of Luxembourg Hospitals (FHL), in partnership with the...

AI Drives Development of Cancer Fighting…

University of Houston researchers and their students are developing a new software technology, based on artificial intelligence, for advancing cell-based immunotherapy to treat cancer and other diseases. CellChorus...

MEDICA 2024 + COMPAMED 2024: Adapted Hal…

11 - 14 November 2024, Düsseldorf, Germany. The final preparations for MEDICA 2024 and COMPAMED 2024 in Düsseldorf have begun. A total of more than 5,500 exhibitors from approximately 70 countries...

Revolutionizing Cardiovascular Risk Asse…

A recent position paper in the Asia-Pacific Journal of Ophthalmology explores the transformative potential of artificial intelligence (AI) in ophthalmology. Led by Lama Al-Aswad, Professor of Ophthalmology and Irene Heinz...

AI does Not Necessarily Lead to more Eff…

The use of artificial intelligence (AI) in hospitals and patient care is steadily increasing. Especially in specialist areas with a high proportion of imaging, such as radiology, AI has long...

Why the NHS Needs a Transparency Revolut…

Opinion Article by Dr Mark Ratnarajah, NHS paediatrician and UK Managing Director for C2-Ai. Wes Streeting wanted 'no stone left unturned' when he asked Lord Darzi to examine the current state...